Correct option is (a) Investigator selection
Easy explanation: After the laboratory studies are over the company submits IND and thus FDA if approves the IND will start the clinical trial phases. In this time the manufacturing company have to choose the Investigator who will investigate and keep a report of the whole process of phase I, II, III, IV.